What is Bausch Health Companies's SG&A?

Bausch Health Companies (BHC) reported SG&A of $861M in Q1 2026.

How has Bausch Health Companies's SG&A changed year-over-year?

Bausch Health Companies's SG&A decreased by 0.7% year-over-year, from $867M to $861M.

What is the long-term trend for Bausch Health Companies's SG&A?

Over 4 years (2021 to 2025), Bausch Health Companies's SG&A has grown at a 7.0% compound annual growth rate (CAGR), from $2.62B to $3.44B.

Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.

Bausch Health Companies BHC SG&A

SG&A at other companies

Bausch + LombBLCO

$544M-3.4%

Johnson & JohnsonJNJ

$6.03B+18.0%

AbbVieABBV

$3.58B+8.7%

OrganonOGN

$424M+1.0%

HRO

HarrowHROW

$43.23M+6.7%

Neurocrine BiosciencesNBIX

$318.5M+15.2%

Segments

By segment

See full

Bausch + Lomb$439M-1.8%

Salix$105M-5.4%

International$63M+21.2%

Diversified$43M-4.4%

Solta Medical$35M+25.0%

Other financials

Income statement

See full

Revenue$2.5B+11.7%

Operating income-$950.0M-444%

Net income-$1.4B-2,353%

EPS (diluted)-$3.82-2,287%

Balance sheet

See full

Cash & equivalents$1.3B+13.4%

Total debt$20.8B-3.5%

Total equity-$2.1B-74.0%

Total assets$24.5B-7.3%

Cash flow

See full

Operating cash flow$230.0M+9.0%

CapEx$109.0M-5.2%

Free cash flow$121.0M+26.0%

Valuation

See full

Market cap$1.79B-15.9%

Enterprise value$21.24B-5.6%

P/S0.2×0.0×

Profitability

See full

Gross margin71.4%—

Operating margin5.6%-10.3pp

Net margin-1.9%-0.9pp

FCF margin9.8%-2.8pp

Returns & leverage

See full

Return on equity-70.1%—

Debt / equity45.2×—

Current ratio1.3×0.0×

Where this comes from

Reported directly by Bausch Health Companies in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Bausch Health Companies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bausch Health Companies's sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bausch Health Companies's SG&A?: Bausch Health Companies (BHC) reported SG&A of $861M in Q1 2026.
How has Bausch Health Companies's SG&A changed year-over-year?: Bausch Health Companies's SG&A decreased by 0.7% year-over-year, from $867M to $861M.
What is the long-term trend for Bausch Health Companies's SG&A?: Over 4 years (2021 to 2025), Bausch Health Companies's SG&A has grown at a 7.0% compound annual growth rate (CAGR), from $2.62B to $3.44B.
What does SG&A mean?: Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.